|
 
 |
| BOOK REVIEW |
|
| Year : 2021 | Volume
: 7
| Issue : 1 | Page : 87 |
|
Emerging technologies for heart disease: A book review
Eli Gabbay
Department of Respiratory Medicine, University of Notre Dame, Fremantle, Australia
| Date of Submission | 20-Feb-2021 |
| Date of Decision | 12-Mar-2021 |
| Date of Acceptance | 04-Apr-2021 |
| Date of Web Publication | 24-Apr-2021 |
Correspondence Address:
Eli Gabbay
Department of Respiratory Medicine, University of Notre Dame, Fremantle
Australia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jpcs.jpcs_14_21
How to cite this article:
Gabbay E. Emerging technologies for heart disease: A book review. J Pract Cardiovasc Sci 2021;7:87 |
Genre : Scientific Literature
Edition : 1st
Year : 2020
Editor : Udi Nussinovitch, MD PhD
Publisher : Academic Press, Elsevier
Release Date : September 2, 2020
Pages : 553 (v1) and 543 (v2)
Rs : 200$ per volume
OCLC : 1173279261 and 1173011968
ISBN : 978-0-12-813706-2 and 978-0-12-813704-8
Language : English
Subject : Cardiovascular Medicine, Technology
Media type : Hardcover, eBook
ASIN : B08GJPRPDF and B08GJPR243
The most difficult challenge faced by an editor of a modern medical text book must be how to maintain relevance as technologies advance. This is particularly so for a textbook titled Emerging Technologies for Heart Disease. Ironically, the book's editor in chief, Udi Nussinovitch, does this in part by ensuring that each chapter begins firmly implanted in a historical perspective. This helps the text have a timeless feel about it. I suspect that even in several years' time, the textbook will maintain its relevancy if only to highlight the timelines and physiological and historical basis on which currently emerging technologies have been formed, many of which will become standards of care.
The two-volume textbook is split into sections covering systolic and diastolic heart failure, valvular disorders, ischemic heart disease, ventricular and supraventricular tachyarrhythmias, as well as bradyarrhythmias. There are specific sections on devices and electronics involved in monitoring and therapy of heart failure and other cardiac diseases. The text appropriately and unapologetically emphasizes newer technologies which are emerging and in many cases, not fully established. In doing so, the editor may be seen to have taken a risk as at least some of these technologies have not yet been optimized and others still may never become part of standard care. Yet in my view, this focus underscores the value of the text. The fact that Nussinovitch has sought and received contributions from a veritable who's who of the cardiac world, from the USA, Canada, Europe, and the editor's native Israel, is testament to the respect with which the editor is held.
I thoroughly enjoyed the text, and have been in equal parts educated and enthralled by its contents and emphasis. I commend it to cardiologists, cardiac scientists, academics, and scholars.
|
Search Pubmed for